Kemira focuses on water treatment strategy, shares on NASDAQ Helsinki radar

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-28, 10:33.

Kemira (FI0009004824) positions itself as a specialist in water-intensive industries. The stock trades on NASDAQ Helsinki, putting it alongside European chemical peers such as BASF in investor comparisons.

Where Kemira makes its money

Kemira reports two main operating segments in recent annual filings: Pulp & Paper and Industry & Water. The Pulp & Paper segment supplies chemicals that improve process efficiency and product quality for paper and board producers.

The Industry & Water segment focuses on municipal and industrial water treatment, including coagulants and polymers for sludge management and purification. This segment is positioned to benefit from long-term demand for clean water infrastructure in Europe and beyond.

Strategic emphasis on water treatment

According to Kemira's latest investor materials, management highlights water treatment solutions as a structural growth area, supported by tightening environmental regulations and infrastructure investments. The company stresses recurring demand from municipalities and industrial clients.

European peers such as BASF and Solvay also report exposure to water treatment chemicals, providing a sector backdrop for Kemira’s strategy. Investors often look at relative valuation and margin profiles within this chemicals cluster.

What the company sells

Kemira’s representative products include coagulants and flocculants used in municipal and industrial water treatment plants. These chemicals help remove impurities and solids from water streams, supporting compliance with regulatory discharge limits.

Where the shares trade today

The Kemira shares (FI0009004824) trade on NASDAQ Helsinki; a live-verified price and timestamp were not available at the time of writing, but the listing remains centered on the Finnish exchange.

This text is for informational purposes and does not constitute investment advice, a buy or sell recommendation, or any form of financial consulting. All data are based on publicly available sources believed to be reliable but may be subject to change.